miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. - Wikidata - awgldk - TriplyDB

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

http://www.wikidata.org/entity/Q34436363

about

Noncoding RNAs in DNA repair and genome integrity Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad Cytoprotection "gone astray": Nrf2 and its role in cancer Health promoting effects of brassica-derived phytochemicals: from chemopreventive and anti-inflammatory activities to epigenetic regulation Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.The DNA damage response: the omics era and its impact.MicroRNAs: novel players in cancer diagnosis and therapies.Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity.miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells The role of microRNAs in ovarian cancer miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma Analysis of tissue and serum microRNA expression in patients with upper urinary tract urothelial cancer.MicroRNA profiling of rats with ochratoxin A nephrotoxicity.The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.MicroRNA as tools and therapeutics in lung cancer A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response.The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.Oxidative stress response and Nrf2 signaling in aging.Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target.Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis.Micro-RNAs associated with the evolution of ovarian cancer cisplatin resistance.Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through.The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells.miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer.MicroRNA-141 inhibits glioma cells growth and metastasis by targeting TGF-β2.miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells

P2860

Q26864697-86BF1E7A-5006-47E3-BE62-50891F2203C5 Q28066915-D87826DB-127B-4119-B281-8BCB8E9AD0DB Q28393784-0D56CF94-10E4-4492-828C-7215A6AD5F05 Q28393960-3D89F46A-ECD0-4253-AA07-5CB04FAC310D Q28539122-3E985447-E3D0-4035-9C1C-1A93C38094E8 Q30244282-BFDA17A0-47D1-4EF0-B1B5-5D78FDC01912 Q33870522-4E8CD71C-2622-4F60-AECB-45F34E20D7B0 Q33914573-2EAA0254-D812-482A-9F8F-A8AF2330AC05 Q34004577-94FBE3AA-58CC-44F4-B06B-8D97EE07A3F3 Q34151444-824FDBE0-A027-41E2-8C4D-B6BC1E792613 Q34253436-5BB201FB-7F06-480C-8CC9-4E78D0EB7C59 Q34786575-579FF182-4EFE-448C-85F8-3CEC8E923B2C Q35023641-EEB35500-EEF7-4FA6-987A-564B03859E50 Q35178777-1137E79D-7F49-4E65-8E0B-5C701C29923B Q35666862-17354D4D-251F-43CC-A27A-14E9A04DAC25 Q35738706-183F7EE8-EE5D-4090-AFCF-311C27907904 Q35739548-01F4AADE-D84B-427F-BA3E-7006241CDF6A Q35813690-0E0AFD7F-1532-4A0C-BEA5-C6441C7FD3BA Q35854310-054D4623-A9DC-4988-830E-295E9DE12CFA Q35870127-D670373A-8F26-49EA-9774-A05F80C4C87D Q35919161-DD2C7AEC-3345-41D4-9DFF-6AE05E11B3E1 Q35924139-ED753150-3277-4E68-87DC-8D1AD261729E Q36079367-47640C0C-2BD0-474C-9C2D-19DEE0226250 Q36185212-96C73625-5660-4CD1-AB40-AE4C7689F050 Q36236785-CB913E55-F296-4EC1-B0BA-0A1B2713857F Q36290193-E75AA47A-AD36-443E-A6A2-104D5C6FECFC Q36293209-FA540B7C-7F28-44DD-B836-3005A0E86E87 Q36304712-63B5FD52-B57A-4461-9214-B1F499B2CD2E Q36320168-1DD3C51D-7580-4736-9AAB-6D7F70C1D33F Q36347167-F36C89DB-847E-480D-987C-06F3338B29B6 Q36387641-00BCC316-9D87-4386-AEF5-9D8C4D7A8D61 Q36390287-F69F54C2-4DF6-4039-B7B4-DA87B2BEAB54 Q36494718-2F2DDDFF-EC48-47BB-BF38-C2B5290679A6 Q36503366-2E184D44-2960-44C4-B802-43DF36C3CDCB Q36679410-AEF4BE31-4723-4EE0-AE23-956BFDFAFE2D Q36775043-9F01C7B7-DF25-4EF6-B2F4-8F442AA11A23 Q36878582-F21E9A95-F404-4E57-96E2-A57C923FCC2D Q37013250-1CD920D5-2806-428C-8934-E7E48FD5AF45 Q37228013-C3EDCC34-F5DC-48B9-A11B-FD31E87248D9 Q37581142-89CDD62A-1282-4FC7-AF3C-2E8371D1230F

P2860

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

http://www.wikidata.org/entity/Q34436363

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@ast

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@en

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@nl

type

label

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@ast

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@en

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@nl

prefLabel

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@ast

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@en

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@nl

P1433

Q34436363-BEFD3226-A5A3-4EAE-8026-47489CF0771C

P1476

Q34436363-2EBF70F0-FE03-4C6D-8CA0-723B98A7142D

P2093

Q34436363-59C2617D-02CC-4AF8-ACA6-A01B7191B580

Q34436363-5B83E321-8473-4990-888D-A6DF73801527

Q34436363-676320C7-D1A7-4F43-8550-8098559E10FE

Q34436363-76727829-12E3-41FE-90A2-EE03B37131B9

Q34436363-7E653A4D-6C65-4E20-90B1-AACAA41DC4FD

Q34436363-7ED903C5-BD58-437A-8558-32ABF6B37A64

Q34436363-9B627C55-022F-4BCF-BECD-409D4C12DEDF

Q34436363-AD59EA67-F04D-4BE1-BC2B-C94AD783D13E

Q34436363-C8ABE44A-A375-48F3-912A-AD76978A4778

Q34436363-CBECEC46-EA06-40F6-B90F-3A40E305BCD7

P2860

Q34436363-00FF28F6-7134-464A-BDEE-595F11DC6A33

Q34436363-017753FA-04C6-4FDB-95F1-50F37DBB6A73

Q34436363-1C2691DE-3E16-4AED-B9A2-F29A79346912

Q34436363-2021F939-D783-4C8B-94D4-013D9E2FBAF6

Q34436363-2290022C-A8F1-4042-B58E-0FA5F76C7C55

Q34436363-23F4B797-39F4-4004-9B0A-12E2FCA2FED1

Q34436363-25EBD461-8A89-4E60-B81D-DCBD2D7D3311

Q34436363-2C988552-9877-43B5-BEC9-7EC992534F0E

Q34436363-2CEFAF3A-7A04-417E-A6EB-343D45986E1C

Q34436363-2FB3A410-55E3-4CAA-8F28-5769F4818E9A

P2888

Q34436363-4151FD3B-6EC8-46DC-9247-DB253F0EF10C

P304

Q34436363-AA3DAFA7-1D88-43D5-B58F-A4D0EFD0F6F4

P31

Q34436363-6A53C556-9240-40FE-A8F0-E510999771D0

P356

Q34436363-299CA36C-7F96-436D-8587-CFBF21F0B5FE

P407

Q34436363-A84FF4E9-636E-4DEE-B1AA-76D0D4D83060

P433

Q34436363-3B17D97E-8B06-4C69-8479-830A21C3D82D

P478

Q34436363-4E84C815-C06F-40C2-8BBF-F9963D25DDA1

P577

Q34436363-5FC6E1EA-3A59-4E33-A740-FC8A4E871683

P5875

Q34436363-E5119F5A-E30A-41C1-8230-25E0CC42AB92

P6179

Q34436363-8FA1A4D6-572D-4160-81C6-20B01BD92138

P698

Q34436363-5E339F68-5A71-4928-A425-CD41FFF77982

P921

Q34436363-AE79ECD8-7C43-45C0-AA93-A762E22DD546

P356

P1433

P1476

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

@en

P2093

A W M Boersma

http://www.w3.org/2001/XMLSchema#string

E A C Wiemer

http://www.w3.org/2001/XMLSchema#string

E Despierre

http://www.w3.org/2001/XMLSchema#string

E M J J Berns

http://www.w3.org/2001/XMLSchema#string

I Vergote

http://www.w3.org/2001/XMLSchema#string

J Helleman

http://www.w3.org/2001/XMLSchema#string

J Pothof

http://www.w3.org/2001/XMLSchema#string

J Verweij

http://www.w3.org/2001/XMLSchema#string

M T M van Jaarsveld

http://www.w3.org/2001/XMLSchema#string

P F van Kuijk

http://www.w3.org/2001/XMLSchema#string

P2860

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

Cloning and characterization of human polyamine-modulated factor-1, a transcriptional cofactor that regulates the transcription of the spermidine/spermine N(1)-acetyltransferase gene

Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Analyzing real-time PCR data by the comparative C(T) method

Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation

hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

P2888

P304

4284-4293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2012.433

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232223435

http://www.w3.org/2001/XMLSchema#string

P6179

1032971129

http://www.w3.org/2001/XMLSchema#string

P698

23045278

http://www.w3.org/2001/XMLSchema#string

P921